NEW USE OF THE VASOACTIVE INTESTINAL PEPTIDE (VIP) AND THE ISOLATED CELLS STIMULATED WITH SUCH PEPTIDE.

摘要

The invention relates to the use of vasoactive intestinal peptide (VIP) for preparing a medicinal product for autoimmune diseases and/or transplant rejection in mammals. The invention also relates to compositions comprising dendritic cells and/or regulatory T cells that are capable of creating peripheral immune tolerance, and to isolated cells contained therein.